| 000 | 01566 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513073254.0 | ||
| 264 | 0 | _c19930901 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrilley, P | |
| 245 | 0 | 0 |
_aComparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cAug 1993 |
||
| 300 |
_a50-4; quiz 55 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xmethods |
| 650 | 0 | 4 |
_aBusulfan _xadministration & dosage |
| 650 | 0 | 4 |
_aCarmustine _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLazarus, H | |
| 700 | 1 | _aTopolsky, D | |
| 700 | 1 | _aCiobanu, N | |
| 700 | 1 | _aCreger, R J | |
| 700 | 1 | _aFox, R M | |
| 700 | 1 | _aBulova, S I | |
| 700 | 1 | _aShina, D C | |
| 700 | 1 | _aGucalp, R | |
| 700 | 1 | _aCooper, B W | |
| 773 | 0 |
_tSeminars in oncology _gvol. 20 _gno. 4 Suppl 4 _gp. 50-4; quiz 55 |
|
| 999 |
_c8341353 _d8341353 |
||